News
Latest News, Announcements, and Press Releases
25Feb 14
Codexis to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on March 11, 2014
REDWOOD CITY, Calif., Feb. 25, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Tuesday,…
read more04Feb 14
Codexis to Present at 16th Annual BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries, today announced that John Nicols, President and CEO of Codexis, will present a company…
read more28Jan 14
Professor Chi-Huey Wong wins 2014 Wolf Prize in Chemistry for work in Biocatalysis
Congratulations to Professor Chi-Huey Wong on winning the 2014 Wolf Prize in Chemistry for his pioneering work in Biocatalysis. Professor Wong has been recognized by the foundation for the development of chemo-enzymatic syntheses “that enable the previously impossible or infeasible…
read more12Nov 13
Codexis Reports Third Quarter 2013 Results and Business Update
— Company immediately begins wind down of CodeXyme® cellulase enzyme program for production of cellulosic sugars for biofuels and bio-based chemicals– — Conference call today at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–Nov. 12, 2013– Codexis, Inc.…
read more05Nov 13
Codexis Appoints Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Nov. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced the appointment of Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development, effective…
read more04Nov 13
Codexis to Announce Third Quarter 2013 Financial Results on November 12, 2013
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Nov. 4, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced it will host a live conference call and audio webcast on Tuesday, November 12, 2013…
read more02Oct 13
Codexis Named Finalist for CPhI Pharma Award for Best Innovation in Process Development
REDWOOD CITY, Calif., Oct 02, 2013 (BUSINESS WIRE) –Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that it has been named as a finalist for the CPhI Pharma Awards…
read more09Aug 13
Codexis Reports Second Quarter 2013 Results
— Conference call on August 15th at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 9, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced financial results for the…
read more05Aug 13
Codexis Receives Notice Alleging Breach of Dyadic License Agreement
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that the company has received notice from Dyadic International, Inc. alleging that Codexis is in…
read more05Aug 13
Codexis Reschedules Second Quarter 2013 Financial Results
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that the company has rescheduled the release of its second quarter financial results due to…
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins® with Codexis
Learn More
Company
Industries